Portal de Periódicos da CAPES

Novel Therapies for Non-Small Cell Lung Cancer

2011; Lippincott Williams & Wilkins; Volume: 26; Issue: 2 Linguagem: Inglês

10.1097/rti.0b013e3182161709

1536-0237

Jessica Donington, Chi Wan Koo, Marc Ballas,

Lung Cancer Research Studies

Lung cancer is the leading cause of cancer-related death in the United States. Emerging technologies for the treatment of early-stage non-small cell lung cancer are currently focused on less invasive approaches to obtaining local tumor control, including minimally invasive and less radical resections, as well as image-guided ablative therapies. Targeted chemotherapeutic agents represent the newest area of treatment for advanced non-small cell lung cancer. These novel agents capitalize on our increased understanding of the diverse biology of the disease. Each of these advanced modalities works best for only a small subset of the population with lung cancer, and efficacious use is highly dependent on appropriate patient selection.